Please assess the completion status of the following clinical trial:

Trial Title: Diagnosis of Chronic Endometritis in Endometrial Fluid Using Molecular Techniques to Improve the Outcomes of Assisted Reproductive Treatments

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who provide their written informed consent after having been informed of the all study aspects.~* IVF or ICSI cycles with own oocytes, with blastocyst transfer (day 5 or 6 of stage development).~* Women with age comprised between 18 and 38 years (both included).~* Body mass index: 18.5 - 30 km/m2 (both included)~* Adequate ovarian reserve \> 8 antral follicles (RFA) and/or Antimüllerian hormone (HAM)\> 1 ng / mL.~* Concentration of spermatozoa \> 2 million sperm/ml.~Exclusion Criteria:~* Congenital or acquired uterine pathologies.~* Endometriosis.~* Patients with IUDs in the last 3 months.~* Patients who have taken prescribed antibiotic treatment in the last 3 months.~* Any disease or medical condition that could be unstable or could endanger the security of the patient and her compliance in the study.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 38 Years
- Healthy Volunteers: t

Study Arms:
- Patients with RIF (Type: None): Patients with repeated implantation failure (RIF) with indication of hysteroscopy within normal clinical practice, who will undergo FIV or ICSI and embryo transfer within their assisted reproduction treatment (ART).

Based on this trial design, predict the completion outcome and termination type (if applicable).